DavidM.PeereboomMD

PubMed

• 1 citations
  Concurrent Lapatinib With Brain Radiation Therapy in Patients With HER2+ Breast Cancer With Brain Metastases: NRG Oncology-KROG/RTOG 1119 Phase 2 Randomized Trial.
  In Ah Kim, Kathryn A Winter, Paul W Sperduto, Jennifer F De Los Santos, David M Peereboom, Tomi Ogunleye, Daniel Boulter, Joel M Fritz, Kwan Ho Cho, Kyung Hwan Shin, I...> ;International Journal of Radiation Oncology, Biology, Physics. 2024 Apr 1
• MGMT Methylation and Differential Survival Impact by Sex in Glioblastoma.
  Addison E Barnett, Ahmad Ozair, Anas S Bamashmos, Hong Li, Assad Ali, Justin D Lathia, Manmeet S Ahluwalia, David S Bosler, Gabrielle Yeaney, David M Peereboom> ;Cancers. 2024 Mar 31
• Secondary somatic glioblastoma arising from a mature ovarian cystic teratoma in a patient with underlying Li-Fraumeni syndrome.
  Parker L Bussies, Danielle B Chau, Jonathan T Hunt, Maria Luisa C Policarpio-Nicolas, Cameron Friedman, Jesse K McKenney, Gabrielle A Yeaney, David M Peereboom, Lindse...> ;Gynecologic Oncology Reports. 2023 Oct 1
• Endoglin inhibitor TRC105 with or without bevacizumab for bevacizumab-refractory glioblastoma (ENDOT): a multicenter phase II trial.
  Manmeet S Ahluwalia, Lisa R Rogers, Rekha Chaudhary, Herbert Newton, Ahmad Ozair, Atulya A Khosla, Andrew B Nixon, Bonne J Adams, Ben K Seon, David M Peereboom, Charle...> ;Communications Medicine. 2023 Sep 8
• 1 citations
  F-fluciclovine PET/CT to distinguish radiation necrosis from tumor progression for brain metastases treated with radiosurgery: results of a prospective pilot study.
  Tom, M., DiFilippo, F., Jones, S., Suh, J., Obuchowski, N., Smile, T., Murphy, E., Yu, J., Barnett, G., Angelov, L., Mohammadi, A., Huang, S., Wu, G., Johnson, S., Pee...> ;Journal of Neuro-Oncology. 2023 Jul 1
• 1 citations
  Combination of EGFR-Directed Tyrosine Kinase Inhibitors (EGFR-TKI) with Radiotherapy in Brain Metastases from Non-Small Cell Lung Cancer: A 2010-2019 Retrospective Coh...
  Vineeth Tatineni, Patrick J O'Shea, Shreya Saxena, Atulya A Khosla, Ahmad Ozair, Rupesh R Kotecha, Xuefei Jia, Yasmeen Rauf, Erin S Murphy, Samuel T Chao, John H Suh, ...> ;Cancers. 2023 Jun 1
• 40 citations
  Oncolytic DNX-2401 virotherapy plus pembrolizumab in recurrent glioblastoma: a phase 1/2 trial.
  Farshad Nassiri, Vikas Patil, Leeor S Yefet, Olivia Singh, Jeff Liu, Rachel M A Dang, Takafumi N Yamaguchi, Mariza Daras, Timothy F Cloughesy, Howard Colman, Priya U K...> ;Nature Medicine. 2023 Jun 1
• 5 citations
  First- versus Third-Generation EGFR Tyrosine Kinase Inhibitors in EGFR-Mutated Non-Small Cell Lung Cancer Patients with Brain Metastases.
  Vineeth Tatineni, Patrick J O'Shea, Ahmad Ozair, Atulya A Khosla, Shreya Saxena, Yasmeen Rauf, Xuefei Jia, Erin S Murphy, Samuel T Chao, John H Suh, David M Peereboom,...> ;Cancers. 2023 Apr 20
• 3 citations
  The role of targeted therapy and immune therapy in the management of non-small cell lung cancer brain metastases.
  Cole Billena, Mina Lobbous, Christine A Cordova, David Peereboom, Alejandro Torres-Trejo, Timothy Chan, Erin Murphy, Samuel T Chao, John Suh, Jennifer S Yu> ;Frontiers in Oncology. 2023 Jan 1
• 3 citations
  Novel Therapeutic Approaches in Neoplastic Meningitis.
  Atulya Aman Khosla, Shreya Saxena, Ahmad Ozair, Vyshak Alva Venur, David M Peereboom, Manmeet S Ahluwalia> ;Cancers. 2022 Dec 25
• 20 citations
  Phase IIa Study of SurVaxM Plus Adjuvant Temozolomide for Newly Diagnosed Glioblastoma.
  Manmeet S Ahluwalia, David A Reardon, Ajay P Abad, William T Curry, Eric T Wong, Sheila A Figel, Laszlo L Mechtler, David M Peereboom, Alan D Hutson, Henry G Withers, ...> ;Journal of Clinical Oncology. 2023 Mar 1
• 2 citations
  Sex-Specific Differences in Low-Grade Glioma Presentation and Outcome.
  Tewari, S., Tom, M., Park, D., Wei, W., Chao, S., Yu, J., Suh, J., Kilic, S., Peereboom, D., Stevens, G., Lathia, J., Prayson, R., Barnett, G., Angelov, L., Mohammadi,...> ;International Journal of Radiation Oncology, Biology, Physics. 2022 Oct 1
• 4 citations
  First clinical experience with belzutifan in von Hippel-Lindau disease associated CNS hemangioblastoma.
  Andrew Dhawan, David M Peereboom, Glen Hj Stevens> ;CNS Oncology. 2022 Jul 12
• 3 citations
  Cognitive function after concurrent temozolomide-based chemoradiation therapy in low-grade gliomas.
  Park, D., Tom, M., Chen, Y., Tewari, S., Ahluwalia, M., Yu, J., Chao, S., Suh, J., Peereboom, D., Stevens, G., Barnett, G., Angelov, L., Mohammadi, A., Hogan, T., Kiss...> ;Journal of Neuro-Oncology. 2022 Jul 1
• 3 citations
  Primary central nervous system lymphoma: Inter-compartmental progression.
  Vishal Raval, Elaine Binkley, Mary E Aronow, Juan Valenzuela, David M Peereboom, Wei Wei, Sunil Srivastava, Jaqueline Davanzo, Herbert Culver Boldt, Mark P McGarrey, G...> ;Ejhaem. 2022 May 1
• Patients with brain metastasis and the risk of falls: a plausibly preventable entity.
  Alejandro Torres-Trejo, David M Peereboom> ;Neuro-Oncology Practice. 2022 Apr 1
• Outcomes of BRAF Mutated vs. Wild Type Tumors in Melanoma Brain Metastasis.
  Patrick Joseph O'Shea, V. Tatineni, Yasmeen Rauf, Xuefei Jia, Erin S. Murphy, Samuel T. Chao, John H. Suh, David M. Peereboom, Manmeet S Ahluwalia> ;International Journal of Radiation Oncology Biology Physics. 2021 Nov 1
• Neurocognitive Function Following Concurrent Radiotherapy and Temozolomide for Adult Patients With Low-Grade Glioma.
  D.Y. Park, M.C. Tom, Yu-Wei Chen, Wei Wei, S. Tewari, Manmeet S Ahluwalia, Jennifer S. Yu, Samuel T. Chao, John H. Suh, David M. Peereboom, Glen Stevens, Gene H. Barne...> ;International Journal of Radiation Oncology Biology Physics. 2021 Nov 1
• 18F-Fluciclovine PET/CT to Distinguish Radiation Necrosis From Tumor Progression in Brain Metastases Treated With Stereotactic Radiosurgery: Results of a Prospective P...
  M.C. Tom, Frank P. DiFilippo, Timothy D. Smile, Stephen E. Jones, John H. Suh, Erin S. Murphy, Jennifer S. Yu, Alireza M. Mohammadi, Gene H. Barnett, Lilyana Angelov, ...> ;International Journal of Radiation Oncology Biology Physics. 2021 Nov 1
• Outcomes of BRAF, MET, RET, and ROS1 Mutated Non-Small Cell Lung Cancer With Brain Metastases (NSCLCBM)
  V. Tatineni, Patrick Joseph O'Shea, Yasmeen Rauf, Xuefei Jia, Erin S. Murphy, Samuel T. Chao, John H. Suh, David M. Peereboom, Manmeet S Ahluwalia> ;International Journal of Radiation Oncology Biology Physics. 2021 Nov 1
• Outcomes of Immune-Checkpoint Inhibitors (ICIs) and Stereotactic Radiosurgery (SRS) in Non-Small Cell Lung Cancer Brain Metastases (NSCLCBM) Patients.
  V. Tatineni, Patrick Joseph O'Shea, Yasmeen Rauf, Xuefei Jia, Erin S. Murphy, Samuel T. Chao, John H. Suh, David M. Peereboom, Manmeet S Ahluwalia> ;International Journal of Radiation Oncology Biology Physics. 2021 Nov 1
• Pulsed Reduced-Dose Rate Re-Irradiation With Intensity Modulated Radiation Therapy (IMRT) for Recurrent Primary Central Nervous System Malignancies.
  A. Halima, Samuel T. Chao, John H. Suh, Jennifer S. Yu, T.A. Chan, S.S. Kilic, David M. Peereboom, Glen Stevens, Yasmeen Rauf, Erin S. Murphy> ;International Journal of Radiation Oncology Biology Physics. 2021 Nov 1
• Impact of Biological Sex on Survival Outcomes in Low-Grade Glioma.
  S.S. Kilic, Kailin Yang, S. Kilic, A. Halima, John H. Suh, T.A. Chan, Jennifer S. Yu, Samuel T. Chao, David M. Peereboom, Yasmeen Rauf, Glen Stevens, Deborah Y. Park, ...> ;International Journal of Radiation Oncology Biology Physics. 2021 Nov 1
• 14 citations
  Primary central nervous system lymphoma - ocular variant: an interdisciplinary review on management.
  Vishal Raval, Elaine M. Binkley, Mary E. Aronow, Juan Valenzuela, David M. Peereboom, Arun D. Singh> ;Survey of Ophthalmology. 2021 Mar 21
• 11 citations
  Phase I trial of intranasal NEO100, highly purified perillyl alcohol, in adult patients with recurrent glioblastoma.
  Axel H. Schönthal, David M. Peereboom, Naveed Wagle, Rose Lai, Anna Mathew, Kyle Hurth, Vincent F Simmon, Steven P. Howard, Lynne Taylor, Frances Chow, Clovis Orlando ...> ;Neuro-Oncology Advances. 2021 Jan 1
• Join now to see all

Journal Articles

• Adjuvant chemotherapy in patients with newly diagnosed non-co-deleted anaplastic gliomas�a new standard  
  Braun KL, Peereboom DM, Transl Cancer Res, 1/1/2018
• Phase 2 trial of SL-701 in relapsed/refractory glioblastoma: Preliminary correlation of immune response with longer-term survival  
  Peereboom DM, Nabors B, Kumthekar P, Badruddoja M, Fink K, Lieberman F, Phuphanich S, Dunbar E, Walbert T, Schiff D, Sherman J, Tran D, Ashby L, Butowski N, Iwamoto F,..., J Clin Oncol, 1/1/2018
• Adjuvant chemotherapy in patients with newly diagnosed non-co-deleted anaplastic gliomas�a new standard  
  Braun KL, Peereboom DM, Translational Cancer Research, 1/1/2018
• Targeting myeloid derived suppressor cells: Phase 0/1 trial of low dose capecitabine + bevacizumab in patients with recurrent glioblastoma  
  Peereboom DM, Lathia JD, Sinyuk M, Ahluwalia MS, Brewer CJ, Vogelbaum MA., Neuro Oncol, 1/1/2016
• NRG/RTOG 1119: Phase II randomized study of whole brain radiotherapy with concurrent lapatinib in patients with brain metastasis from Her2-positive breast cancer: A co...  
  Peereboom DM, Moughan J, Kim IA, De Los Santos JF, Sperduto PW, White JR, Mehta MP, Neuro Oncol, 1/1/2016
• Combination of Radiotherapy and Targeted Agents in Brain Metastasis: An Update  
  Aly Z, Peereboom DM, Curr Treat Options Neurol, 1/1/2016
• Efficacy and patient-reported outcomes with dose-intense temozolomide in patients with newly diagnosed pure and mixed anaplastic oligodendroglioma: a phase II multicen...  
  Ahluwalia MS, Xie H, Dahiya S, Hashemi-Sadraei N, Schiff D, Fisher PG, Chamberlain MC, Pannullo S, Newton HB, Brewer C, Wood L, Prayson R, Elson P, Peereboom DM., J Neurooncol, 1/1/2015
• The Cleveland Clinic experience with primary central nervous system lymphoma  
  Xie H, Ahluwalia MS, Peereboom DM., Am J Clin Oncol, 1/1/2015
• RTOG 1119: Phase II randomized study of whole brain radiotherapy with concurrent lapatinib in patients with brain metastasis from HER2-positive breast cancer�A collabo...  
  Peereboom DM, Winter KA, Kim IA, De Los Santos JF, Sperduto PW, White JR, Mehta MP, J Clin Oncol, 1/1/2014
• NABTT 0502: a phase II and pharmacokinetic study of erlotinib and sorafenib for patients with progressive or recurrent glioblastoma multiforme  
  Peereboom DM, Ahluwalia MS, Ye X, Supko JG, Hilderbrand SL, Phuphanich S, Nabors LB, Rosenfeld MR, Mikkelsen T, Grossman SA, Neuro Oncol, 1/1/2013
• Phase I study of terameprocol in patients with recurrent high-grade glioma  
  Grossman SA, Ye X, Peereboom DM, Rosenfeld MR, Mikkelsen T, Supko JG, Desideri S; for the Adult Brain Tumor Consortium, Baltimore, MD, Neuro Oncol, 1/1/2012
• Clinical trial design in brain metastasis: approaches for a unique patient population  
  Peereboom DM., Curr Oncol Rep, 1/1/2012
• Ogilvie's syndrome during chemotherapy with high-dose methotrexate for primary CNS lymphoma  
  Xie H, Peereboom DM, J Clin Oncol, 1/1/2012
• Clinical trial design in brain metastasis: Approaches for a unique patient population  
  Peereboom DM, Curr Oncol Rep., 1/1/2012
• A phase II and pharmacodynamic trial of RO4929097 for patients with recurrent/progressive glioblastoma  
  Peereboom DM, Rich JN, Supko JG, Lamborn K, Ye X, Sloan AE, Prados M, Grossman SA, Adult Brain Tumor Consortium (ABTC)., Neuro-Oncol, 1/1/2012
• Phase II trial of sunitinib as adjuvant therapy after stereotactic radiosurgery (SRS) in patients with 1-3 newly diagnosed brain metastases  
  Peereboom DM, Chao ST, Suh JH, Wang D, Mikkelsen T, Brewer CJ, Smolenski KN, Parsons MW, Elson P, Angelov L, Barnett GH, Vogelbaum MA, Weil RJ, J Clin Oncol, 1/1/2012
• Capecitabine entry into brain metastases in women with breast cancer  
  Peereboom DM, Seidman AD, Tabar V, Weil RJ, Thorsheim HR, Smith QR, Lockman PR, Steeg PS., Neuro-Oncol, 1/1/2012
• Ogilvie Syndrome during chemotherapy with high-dose methotrexate for primary CNS lymphoma  
  Xie H, Peereboom DM, J Clin Oncol, 1/1/2012
• Phase II trial of ritonavir/lopinavir in patients with progressive or recurrent high-grade gliomas  
  Ahluwalia MS, Patton C, Stevens G, Tekautz T, Angelov L, Vogelbaum MA, Weil RJ, Chao S, Elson P, Suh JH, Barnett GH, Peereboom DM., J Neurooncol, 1/1/2011
• Role of tyrosine kinase inhibitors in the management of high-grade gliomas  
  Ahluwalia MS, Patel M, Peereboom DM, Expert Rev Anticancer Ther, 1/1/2011
• Aggressive treatment is appropriate for glioblastoma multiforme patients 70 years old or older: a retrospective review of 206 cases  
  Scott JG, Suh JH, Elson P, Barnett GH, Vogelbaum MA, Peereboom DM, Stevens GH, Elinzano H, Chao ST., Neuro Oncol, 1/1/2011
• Treatment outcomes for patients with glioblastoma multiforme and a low Karnofsky Performance Scale score on presentation to a tertiary care institution  
  Marina O, Suh JH, Reddy CA, Barnett GH, Vogelbaum MA, Peereboom DM, Stevens GH, Elinzano H, Chao ST, J Neurosurg, 1/1/2011
• A phase II and pharmacodynamic trial of RO4929097 for patients with recurrent/progressive glioblastoma  
  Peereboom DM, Rich JN, Supko JG, Lamborn K, Ye X, Sloan AE, Prados M, Grossman SA, Adult Brain Tumor Consortium (ABTC)., J Clin Oncol, 1/1/2011
• A phase I/II trial and pharmacokinetic study of ixabepilone in adult patients with recurrent high-grade gliomas  
  Peereboom DM, Supko JG, Carson KA, Batchelor T, Phuphanich S, Lesser G, Mikkelsen T, Fisher J, Desideri S, He X, Grossman SA for The New Approaches to Brain Tumor Ther..., J Neurooncol, 1/1/2010
• A multi-institution phase II study of poly-ICLC and radiotherapy with concurrent and adjuvant temozolomide in adults with newly diagnosed glioblastoma  
  Rosenfeld MR, Chamberlain MC, Grossman SA, Peereboom DM, Lesser GJ, Batchelor TT, Desideri S, Salazar AM, Ye X., Neurooncol, 1/1/2010
• Join now to see all

Books/Book Chapters

• Glioblastoma 
  Chapter: Lessons Learned: Clinical Trials and other Interventions for Glioblastoma 
  Page 279.0 - 290.0Bernatowicz R, Peereboom DM.Editors: Brem S, Abdullah KG.Elsevier, Inc, Atlanta2017
• Glioblastoma 
  Chapter: Lessons Learned: Clinical Trials and other Interventions for Glioblastoma. 
  Page 279.0 - 290.0Bernatowicz R, Peereboom DMEditors: Brem S, Abdullah KG.Elsevier, Inc, Atlanta2017
• DeVita, Hellman, and Rosenberg's Cancer: Principles and Practice of Oncology 
  Chapter: Metastatic Cancer to the Brain 
  Page 1832. - 1844.Suh JH, Chao ST, Peereboom DM, Barnett, GHEditors: DeVita VT, Lawrence TS, Rosenberg SA, DePinho RA, Weinberg RA.Lippincott Williams & Wilkins, PhiladelphiaEdition 10th,2015
• Clinical Ophthalmic Oncology. Retinal Tumors 
  Chapter: Primary central nervous system and retinal lymphoma 
  Page 75.0 - 90.0Ahluwalia MS, Dahiya S, Aronow ME, Peereboom DM, Singh AD.Editors: Singh AD, Damato B.Springer, HeidelbergEdition 2nd,2014
• Retina 
  Chapter: Primary vitreoretinal lymphoma. 
  Page 2373. - 2378.Turell ME, Schachat AP, Peereboom DM, Singh AD.Editors: Ryan SJ.Saunders/Elsevier, LondonEdition 5th,2013
• Clinical Ophthalmic Oncology 
  Chapter: Lymphoma of the retina and CNS. 
  Page 372.0 - 377.0Singh AD, Lewis H, Schachat AP, Peereboom DM.Editors: Singh AD, Damato BE, Pe'er J, Murphree AL, Perry JD.Sunders-Elsevier, Philadelphia2007
• Diagnosis and Treatment, Current Clinical Oncology Series 
  Chapter: Chemotherapy for High-Grade Gliomas. 
  Page 267.0 - 282.0Ahluwalia M, Peereboom DEditors: GH Barnett.Humana Press, Totowa, NJ2007
• Diagnosis and Treatment, Current Clinical Oncology Series 
  Chapter: Chemotherapy for High-Grade Gliomas 
  Page 267.0 - 282.0Ahluwalia MS, Peereboom DEditors: Barnett GH.Humana Press, Totowa, NJ2006
• Office Urology: The Clinician's Guide 
  Chapter: Prostate Cancer: Endocrine Therapy 
  Page 291.0 - 301.0Daw HA, Peereboom DMEditors: Kursh ED, Ulchaker JC.Humana Press, Totowa, NJ2001
• Regional Chemotherapy: Clinical Research and Practice 
  Chapter: Principles of Intrathecal Chemotherapy 
  Page 305.0 - 317.0Stevens GH, Peereboom DMEditors: Markman M.Humana Press, Totowa, NJ2000
• Renal Cell Carcinoma: Molecular Biology, Immunology, and Clinical Management 
  Chapter: Paraneoplastic Syndromes 
  Page 135.0 - 145.0Aldaabil R, Peereboom DM.Editors: Bukowski RM, Novick A.Humana Press, Totowa, NJ2000
• Renal Cell Carcinoma: Molecular Biology, Immunology, and Clinical Management 
  Chapter: Paraneoplastic Syndromes. 
  Page 135.0 - 145.0Aldaabil R, Peereboom DM.Editors: Bukowski RM, Novick A.Humana Press, Totowa, NJ2000
• Medicine for the Practicing Physician 
  Chapter: Essential Thrombocytosis. 
  Page 858.0 - 859.0Peereboom DM.Editors: Hurst JW.Appleton and Lange, Simon and Schuster, StamfordEdition 4th,1996
• Medicine for the Practicing Physician 
  Chapter: Polycythemia Vera. 
  Page 862.0 - 865.0Peereboom DM.Editors: Hurst JW.Appleton and Lange, Simon and Schuster, StamfordEdition 4th,1996
• Medicine for the Practicing Physician 
  Chapter: Idiopathic Myelofibrosis 
  Page 869.0 - 871.0Peereboom DMEditors: Hurst JW.Appleton and Lange, Simon and Schuster, StamfordEdition 4th,1996
• Biology of Renal Cell Carcinoma 
  Chapter: Cytokine therapy of metastatic renal cell carcinoma: The Cleveland Clinic experience 
  Page 189.0 - 203.0Bukowski RM, Olencki T, Peereboom D, Budd GT, Murthy S, Tubbs R, Rayman P, McLain D, Klein E, Tuason L, Finke J.Editors: Bukowski RM, Finke JH, Klein EA.Springer-Verlag, New York1995
• Join now to see all

Abstracts/Posters

• Circulating Endothelial Cells in Recurrent Glioblastoma.
  Stockham A, Borden E, Peereboom DM., Society for Neuro-Oncology Meeting, Orange County, CA, 1/1/2011
• Ogilvie�s syndrome during chemotherapy of primary central nervous system lymphoma
  Xie H, Peereboom DM., The American College of Physician National Meeting, San Diego, CA, 1/1/2011
• Primary central nervous system lymphoma: the Cleveland Clinic experience
  Xie H, Peereboom DM., Lepow Research Day, Case Western Reserve University, Cleveland, OH, 1/1/2011
• Quality of life analysis for clinical trial of temozolomide in patients with anaplastic oligodendrogliomas
  Hashemi-Sadraei, N, Brewer C, Schiff D, Fisher P, Chamberlain M, Pannullo S, Snodgrass S, Newton H, Elson P, Prayson R, Staugaitis S, Stevens G, Toms S, Vogelbaum M, B..., Proc Am Soc Clin Oncol, American Society for Clinical Oncology meeting, Chicago IL, 1/1/2010
• Phase II trial of patupilone in patients with breast cancer brain metastases.
  Kang T, Brewer C, Jin T, Conlin A, Seidman A, Peereboom D., Society of Neuro-Oncology Meeting, Dallas, TX, 1/1/2007
• Irinotecan and bevacizumab in progressive primary brain tumors: The Cleveland Clinic experience
  Kang TY, Jin T, Elinzano H, Peereboom D., Proc Am Soc Clin Oncol, American Society for Clinical Oncology meeting, Chicago IL, 1/1/2007
• Phase II multicenter study of 7/7 dosing of temozolomide in patients with newly diagnosed pure and mixed anaplastic oligodendroglioma.
  Kaur H, Wood L, Schiff D, Barnett G, Vogelbaum M, Stevens G, Prayson R, Staugaitis S, Elson P, Peereboom D., Proc Am Soc Clin Oncol, American Society for Clinical Oncology meeting, Chicago IL, 1/1/2003
• Join now to see all

Lectures

• Phase 2 trial of SL-701 in relapsed/refractory (r/r) glioblastoma (GBM): Correlation of immune response with longer-term survival. 
  2018 ASCO Annual Meeting - Chicago, Illinois - 06/2/2018
• Chemotherapy in Neuro-Oncology: Principles and Practice 
  New Orleans, LA - 1/1/2018
• Systemic Therapy for Meningiomas 
  Santa Monica, CA - 1/1/2018
• Update in Neuro-Oncology 
  Cleveland, OH - 1/1/2018
•  
  Munich, Germany - 1/1/2018
• CNS Metastases Oral Abstracts 
  New Orleans, LA - 1/1/2018
• Targeting myeloid derived suppressor cells: Phase 0/1 trial of low dose capecitabine + bevacizumab in patients with recurrent glioblastoma 
  New Orleans, LA - 1/1/2018
• Chemotherapy Principles and Practice in Neuro-Oncology 
  1/1/2017
• Central Nervous System Tumors 
  1/1/2017
• Highlights of the Day � CNS Malignancies 
  Chicago, IL - 1/1/2017
• Perspective on Treating Patients with Newly Diagnosed Primary CNS Lymphoma 
  Skamania, WA - 1/1/2017
• Current Therapeutic Approaches and Theoretical Paradigms in CNS Metastases: What is the Role of the Neurovascular Bundle? 
  Skamania, WA - 1/1/2017
• Chemotherapy in Brain Metastases: Strategies for Treatment, Prevention and Progress 
  Skamania, WA - 1/1/2017
• Update on Brain Metastases 
  Skamania, WA - 1/1/2017
• Use of Bevacizumab in Brain Tumors 
  Skamania, WA - 1/1/2017
• Update on Brain Metastases from Breast and Lung Cancer 
  Skamania, WA - 1/1/2017
• The Impact of the Neurovascular Unit in CNS Metastases 
  Skamania, WA - 1/1/2017
• Chemotherapy for Breast Cancer Brain Metastases 
  Skamania, WA - 1/1/2017
• Primary and Metastatic Brain Tumors: Is More Treatment Better than Less? 
  Skamania, WA - 1/1/2017
• Principles of Chemotherapy and Emerging Treatments in Breast Cancer Brain Metastases 
  Las Vegas, NV - 1/1/2016
• Primary CNS Lymphoma 
  1/1/2016
• Immunotherapy 
  1/1/2016
• Vestibular Schwannomas: Early Observation and Systemic Management 
  Las Vegas, NV - 1/1/2015
• Brain Metastasis: Management in 2015 
  1/1/2015
• Systemic Therapy for Tumors of the Skull Base 
  Las Vegas, NV - 1/1/2014
• Join now to see all

Other

• Audio cast �Update in Brain Tumors� 
  Research to Practice
  Cleveland, OH - 1/1/2010
• Malignant Glioma Update Think Tank 
  Research to Practice
  Miami, FL - 1/1/2009
• Current Clinical Research Data on Bevacizumab in High Grade Gliomas 
  Research to Practice
  Miami, FL - 1/1/2009
• Human Epidermal Growth Factor Receptor-Family Education Network Curriculum 
  Development/Review 2003-2004, Teaching Slide Set Development, Genentech
  New York, NY - 1/1/2004
• Teaching Slide Set Development 
  Schering Plough
  Dallas, TX - 1/1/2004
• �Spinal Cord Compression� Video in-service 
  Hematology/Oncology Nursing Unit, Cleveland Clinic Foundation
  Cleveland, OH - 1/1/2003
• Join now to see all